WHO updates rules calling for methadone or buprenorphine for OUD

The World Health Organization (WHO) has called on treatment providers worldwide to rely on two treatments for opioid use disorder (OUD): methadone and buprenorphine. Worldwide, OUD is a major contributor to morbidity and mortality. According to WHO, of 600,000 deaths attributed to drug use, about 450,000 are due to opioid use.

Authors

Publication Details

Journal
Alcoholism & Drug Abuse Weekly
Published
2026-04-10
DOI
https://doi.org/10.1002/adaw.34876
Primary Topic
Opioid Use Disorder Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

WHO updates rules calling for methadone or buprenorphine for OUD

Alison Knopf
Alcoholism & Drug Abuse Weekly
Opioid Use Disorder Treatment
article

WHO updates rules calling for methadone or buprenorphine for OUD

Alison Knopf
article en

Abstract

The World Health Organization (WHO) has called on treatment providers worldwide to rely on two treatments for opioid use disorder (OUD): methadone and buprenorphine. Worldwide, OUD is a major contributor to morbidity and mortality. According to WHO, of 600,000 deaths attributed to drug use, about 450,000 are due to opioid use.

Alcoholism & Drug Abuse WeeklyVol. 38(15)
Good health and well-being
Openalex Percentile: Top 5%
Opioid Use Disorder Treatment
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.